EMPOWER-Lung3: Cemiplimab Plus Chemotherapy in Advanced NSCLC

Edgardo Santos, MD, FACP, FCCP, analyzes the influence on clinical practice arising from the application of cemiplimab with chemotherapy in advanced non-small cell lung cancer (NSCLC) observed in the EMPOWER-Lung3 trial.

Related Keywords

,Recent Advancements ,Treatment Approaches ,Non Small Cell Lung Cancer ,Nsclc ,Lung Cancer ,Advanced Nsclc ,Advanced Non Small Cell Lung Cancer ,Empower Lung3 ,Cemiplimab ,Chemotherapy ,Nsclc Treatment ,Non Small Cell Lung Cancer Treatment ,